XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common stock issued
Donated shares
Additional paid-in capital
Statutory reserves
Accumulated deficit
Accumulated other comprehensive loss
Non-controlling interests
Treasury shares
Total
Balance at Dec. 31, 2019 $ 53,222 $ 14,101,689 $ 180,208,610 $ 1,230,511 $ (176,177,413) $ (1,744,730) $ 52,777 $ (4,066,610) $ 13,658,056
Balance (in Shares) at Dec. 31, 2019 53,220,902             (144,206)  
Net profit (loss)         (2,359,981)   5,870   (2,354,111)
Share-based compensation for employee and director stock awards     300,135           300,135
Common stock issued to investors $ 368   199,632           200,000
Common stock issued to investors (in Shares) 367,897                
Foreign currency translation adjustment           (301,215) (830)   (302,045)
Balance at Mar. 31, 2020 $ 53,590 14,101,689 180,708,377 1,230,511 (178,537,394) (2,045,945) 57,817 $ (4,066,610) 11,502,035
Balance (in Shares) at Mar. 31, 2020 53,588,799             (144,206)  
Balance at Dec. 31, 2020 $ 79,310 14,101,689 225,278,113 1,230,511 (183,984,311) (239,609) 7,735 $ (4,066,610) 52,406,828
Balance (in Shares) at Dec. 31, 2020 79,310,249             (144,206)  
Net profit (loss)         29,609,282   (1,114)   29,608,168
Share-based compensation for employee and director stock awards     148,818           148,818
Issuance of common stock and warrants $ 8,940   15,621,071           15,630,011
Issuance of common stock and warrants (in Shares) 8,939,976                
Foreign currency translation adjustment           94,041 (4,903)   89,138
Balance at Mar. 31, 2021 $ 88,250 $ 14,101,689 $ 241,048,002 $ 1,230,511 $ (154,375,029) $ (145,568) $ 1,718 $ (4,066,610) $ 97,882,963
Balance (in Shares) at Mar. 31, 2021 88,250,225             (144,206)